Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There are few data on the prevalence of obesity and its influence on achieving blood glucose, blood pressure, and blood lipid (3B) goals in Chinese type 2 diabetes outpatients. METHODS: Patient demographic data, anthropometric measurements, medications, and blood glucose and lipid profiles of 24,512 type 2 diabetes patients from a large, geographically diverse study (CCMR-3B) were analyzed. Using cut-points for body mass index (BMI) and waist circumference (WC) recommended by the Working Group on Obesity in China, overweight and obesity were defined as BMIs of 24-27.9 kg/m2 and ≥28.0 kg/m2. Central obesity was defined as a waist circumference ≥80 cm in women and ≥85 cm in men. The 3B therapeutic goals were HbA1c<7.0%, BP<140/90 mmHg and LDL-C<2.6 mmol/L. RESULTS: Overall, 43.0% of type 2 diabetes patients were overweight and 16.7% were obese; 13.3% of overweight and and 10.1% of obese patients achieved all the 3B target goals. Overweight or obese patients were less likely to achieve 3B goals than those with normal BMIs. More than a half the overweight or obese patients (69.6%) were centrally obese. Patients with abdominal obesity were less likely to achieve cardiometabolic targets than those without abdominal obesity. In multivariate logistic regression analysis, female, higher BMI and waist circumference, smoking, drinking, sedentary lifestyle, and longer diabetes duration were significantly correlated with failure to achieve 3B control goals. CONCLUSIONS: Obesity is highly prevalent and associated with poor 3B control in Chinese type 2 diabetes patients. In clinical practice, more attention and resources should focus on weight loss for such patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to that observed in western countries, a study in China found that 50.3% of T2D patients were not overweight,34”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“However, in some Asian countries, ~50% of patients are not overweight.34,35”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Self-citationCardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
(2002) · PubMed · Cited by 1,755
Bei‐Fan, Z., & the Cooperative Meta‐analysis Group of Working Group on Obesity in China (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.11.s8.9.x · Cited by 1,270
Zhou, Cooperative, B.-F., & on (2002) · 生物医学与环境科学:英文版 · Cited by 992
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Association of Weight Status With Mortality in Adults With Incident Diabetes
Carnethon, M. R., De Chavez, P. J. D., Biggs, M. L., Lewis, C. E., Pankow, J. S., Bertoni, A. G., Golden, S. H., Liu, K., Mukamal, K. J., Campbell-Jenkins, B., et al. (2012) · JAMA · doi:10.1001/jama.2012.9282 · Cited by 567 · cited 1×
“A meta-analysis of five longitudinal cohort studies demonstrated that overweight or obese diabetes patients had a twofold greater relative risk of mortality than normal-weight patients [7].”
Prevalence of Diabetes and Its Risk Factors in China, 1994
Pan, X.-R., Yang, W.-Y., Li, G.-W., Liu, J., & National Diabetes Prevention and Control Cooperative Group (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1664 · Cited by 491
Overweight and obesity in China
Wu, Y. (2006) · BMJ · doi:10.1136/bmj.333.7564.362 · Cited by 454
(2002) · PubMed · Cited by 413
Colosia, A., Khan, S., & Palencia, R. (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s51325 · Cited by 369 · cited 2×
“Hyperglycemia, hypertension, and dyslipidemia occur frequently in type 2 diabetes patients [19,20].”
BackgroundDaousi, C., Casson, I. F., Gill, G. V., MacFarlane, I. A., Wilding, J. P. H., & Pinkney, J. H. (2006) · Postgraduate Medical Journal · doi:10.1136/pmj.2005.039032 · Cited by 351 · cited 1×
“Obese (BMI 30kg/m(2)) type 2 diabetes patients treated at a clinic in the UK had higher blood pressure and triglyceride levels than nonobese patients, and that total cholesterol and glycemic control were worse in obese than nonobese male patients [22].”
BackgroundDyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
Chehade, J. M., Gladysz, M., & Mooradian, A. D. (2013) · Drugs · doi:10.1007/s40265-013-0023-5 · Cited by 290
Ji, L., Hu, D., Pan, C., Weng, J., Huo, Y., Ma, C., Mu, Y., Hao, C., Ji, Q., Ran, X., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.035 · Cited by 254 · cited 1×
“The study design and population have been described previously [12].”
MethodSelf-citationFujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244 · cited 1×
“Our findings confirm the negative impact of obesity on achieving 3B treatment goals, and that the negative effects were not offset by pharmacotherapy, emphasizing the known benefit of weight loss in diabetes patients [26,27].”
Result8. Cardiovascular Disease and Risk Management
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s011 · Cited by 233
Hou, X., Lu, J., Weng, J., Ji, L., Shan, Z., Liu, J., Tian, H., Ji, Q., Zhu, D., Ge, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057319 · Cited by 172
Self-citationReeder, B. A., Angel, A., Ledoux, M., Rabkin, S. W., Young, T. K., & Sweet, L. (1992) · Europe PMC (PubMed Central) · Cited by 149
Qin, L., Knol, M. J., Corpeleijn, E., & Stolk, R. P. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-009-9395-y · Cited by 126 · cited 3×
“Physical activity may increase insulin sensitivity, glucose disposal, and oxidation of free fatty acids [29].”
BackgroundInfluentialRyan, A. S., Ge, S., Blumenthal, J. B., Serra, M. C., Prior, S. J., & Goldberg, A. P. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12749 · Cited by 91 · cited 1×
“Moreover, the benefits of physical activity may extend beyond weight loss alone to include reduction of systemic and vascular inflammation [30].”
BackgroundJones, D. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00123-5 · Cited by 89 · cited 1×
“Our findings confirm the negative impact of obesity on achieving 3B treatment goals, and that the negative effects were not offset by pharmacotherapy, emphasizing the known benefit of weight loss in diabetes patients [26,27].”
ResultPrevalence of obesity and associated cardiovascular risk: the DARIOS study
Félix-Redondo, F. J., Grau, M., Baena-Díez, J. M., Dégano, I. R., de León, A. C., Guembe, M. J., Alzamora, M. T., Vega-Alonso, T., Robles, N. R., Ortiz, H., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-542 · Cited by 69
中华医学会糖尿病学分会 (2014) · Chin J Diabetes Mellitus · doi:10.3760/cma.j.issn.1674-5809.2014.07.004 · Cited by 50
Ji, L., Li, H., Guo, X., Yan, L., Hu, R., & Zhu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057222 · Cited by 40 · cited 1×
“A clinical trial conducted in Chinese patients with newly diagnosed type 2 diabetes reported no differences in the efficacy of metformin monotherapy to reduce HbA1c and LDL-C levels in normal weight, overweight, or obese patients after 16 weeks of treatment [24].”
BackgroundSelf-citationBelletti, D. A., Zacker, C., & Wogen, J. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-7 · Cited by 31
Iwahashi, H., Okauchi, Y., Ryo, M., Noguchi, M., Morita, S., Kishida, K., Okita, K., Ohira, T., Funahashi, T., Nakamura, T., et al. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00180.x · Cited by 28 · cited 1×
“reported that after oral glucose loading, insulin levels were higher in obese than in non-obese type 2 diabetes patients [21].”
BackgroundControl to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus
Okafor, C., & Ofoegbu, E. (2012) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.94089 · Cited by 23 · cited 2×
“Cardiovascular events contribute to morbidity and mortality from diabetes, but control of cardiometabolic risk factors among diabetes patients is reported to be poor [8].”
BackgroundSaid, Q., Marx, C. M., Schwartz, J. S., Ben-Joseph, R. H., & Brixner, D. I. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00649.x · Cited by 9
Pan, C., Han, P., Ji, L., Ji, Q., Lu, J., Lin, J., Liu, J., Su, B., Shi, J., & Wang, P. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12179 · Cited by 2 · cited 1×
“Another observational study reported similar reductions of glycaemia in patients with different BMIs after insulin detemir was added to treatment regimens that included oral glucose lowering drugs [25].”
BackgroundSelf-citation
Research works printed but not linked: 1
- 2014, China Guideline for Type 2 Diabetes, Chin J Diabetes Mellitus, 6, 447
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
on behalf of CCMR-3B STUDY Investigators, Tao, X., Li, J., Zhu, X., Zhao, B., Sun, J., Ji, L., Hu, D., Pan, C., Huang, Y., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0376-7 · Cited by 80
“The study design and population have been previously described [15, 16].”
MethodSelf-citationKenawy, E., Seggiani, M., Cinelli, P., Elnaby, H. M. H., & Azaam, M. M. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.109769 · Cited by 71
Zhang, P., Wang, R., Gao, C., Jiang, L., Lv, X., Song, Y., & Li, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160402 · Cited by 64
“Both of them indicated that hypertension, diabetes and hyperlipidemia had a positive association with central obesity, which is consistent with previous studies [27, 28].”
ResultAssociation of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects
Anari, R., Amani, R., Latifi, S. M., Veissi, M., & Shahbazian, H. B. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.07.004 · Cited by 71
Metadata
- Authors
- Zhou, X., Ji, L., Ran, X., Su, B., Ji, Q., Pan, C., Weng, J., Ma, C., Hao, C., Zhang, D., Hu, D., & CCMR Advisory Board and CCMR-3B Study Investigators
- Affiliations
- Peking University (CN)
- Sichuan University (CN)
- Dalian Medical University (CN)
- Xijing Hospital (CN)
- Chinese PLA General Hospital (CN)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- VitalStrategic Research Institute (US)
- Peking University People's Hospital (CN)
- Corresponding author
- Ji, Linong
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-04
- Volume
- 11
- Issue
- 1
- Pages
- e0144179
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4699817
- OpenAlex
- W2225024458
- Cited by
- 56
- References
- 34
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 5
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- obesity, type 2 diabetes, glycemic control, blood pressure control, lipid control, overweight, abdominal obesity, waist circumference, body mass index, Chinese patients, weight loss
- MeSH terms
- Adult, Aged, Alcohol Drinking, Blood Glucose, China, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Lipids, Male, Middle Aged, Obesity, Outpatients, Risk Factors, Smoking, Time Factors, Comorbidity, Body Mass Index, Asian People, Dyslipidemias, Overweight, Waist Circumference, Obesity, Abdominal, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.